RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q1 2025 · 248 positions · Total reported value $1.70B · Top-10 concentration 26.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 248 equity positions with a combined reported value of $1.70B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 26.3% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q1 2025 were LRN ($58.76M), VRNA ($52.25M), ACIW ($50.64M). By sector, the heaviest allocations are Consumer Discretionary 27.3%, Health Care 25.2%. Versus the prior quarter, allocation shifted toward Other (+0.9pp), Health Care (+0.5pp) and away from Consumer Discretionary (-1.0pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 93% of names.

The largest new positions opened in Q1 2025 were GTLS ($6.64M), FIBK ($2.47M), MRCY ($1.99M).

Of the 12 positions fully exited versus the prior quarter, the largest were HLIT ($3.61M), CDMO ($3.04M), ZUO ($2.87M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • GTLS CHART INDS INC · $6.64M
  • FIBK FIRST INTST BANCSYSTEM INC · $2.47M
  • MRCY MERCURY SYS INC · $1.99M
  • AUPH AURINIA PHARMACEUTICALS INC · $1.81M
  • HLIO HELIOS TECHNOLOGIES INC · $1.80M
  • NGS NATURAL GAS SVCS GROUP INC · $1.46M
  • RHLD RESOLUTE HLDGS MGMT INC · $655.10K
  • PLBC PLUMAS BANCORP · $239.85K

Fully Exited (vs previous quarter)

  • HLIT HARMONIC INC · prev qtr: $3.61M
  • CDMO AVID BIOSERVICES INC · prev qtr: $3.04M
  • ZUO ZUORA INC · prev qtr: $2.87M
  • ELF E L F BEAUTY INC · prev qtr: $2.48M
  • RVNC REVANCE THERAPEUTICS INC · prev qtr: $2.06M
  • ZYXIQ ZYNEX INC · prev qtr: $1.83M
  • QRHC QUEST RESOURCE HLDG CORP · prev qtr: $1.77M
  • STAA STAAR SURGICAL CO · prev qtr: $1.15M

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 25.2%
Technology 16.5%
Financials 5.2%
Other 13.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 464.51K $58.76M 3.45%
3.45%
Reduce
2 823.01K $52.25M 3.07%
3.07%
Reduce
3 925.68K $50.64M 2.98%
2.98%
Reduce
4 787.15K $48.40M 2.84%
2.84%
Hold
5 545.13K $46.86M 2.75%
2.75%
Reduce
6 303.12K $46.32M 2.72%
2.72%
Reduce
7 4.00M $39.48M 2.32%
2.32%
Reduce
8 825.98K $36.10M 2.12%
2.12%
Reduce
9 322.57K $34.47M 2.03%
2.03%
Reduce
10 827.42K $33.76M 1.98%
1.98%
Add
11 103.13K $31.42M 1.85%
1.85%
Reduce
12 297.22K $31.25M 1.84%
1.84%
Reduce
13 163.79K $30.71M 1.80%
1.80%
Reduce
14 704.44K $29.97M 1.76%
1.76%
Add
15 343.75K $28.09M 1.65%
1.65%
Add
16 194.38K $27.38M 1.61%
1.61%
Reduce
17 1.06M $27.38M 1.61%
1.61%
Reduce
18 244.78K $26.33M 1.55%
1.55%
Reduce
19 434.87K $25.24M 1.48%
1.48%
Reduce
20 160.80K $25.06M 1.47%
1.47%
Reduce
21 122.83K $24.26M 1.43%
1.43%
Reduce
22 263.73K $24.13M 1.42%
1.42%
Add
23 144.85K $22.74M 1.34%
1.34%
Add
24 601.57K $22.61M 1.33%
1.33%
Add
25 859.72K $18.59M 1.09%
1.09%
Reduce
26 489.92K $17.72M 1.04%
1.04%
Reduce
27 210.62K $17.67M 1.04%
1.04%
Reduce
28 853.02K $17.29M 1.02%
1.02%
Reduce
29 515.89K $16.90M 0.99%
0.99%
Reduce
30 2.01M $16.40M 0.96%
0.96%
Add
31 163.39K $16.39M 0.96%
0.96%
Reduce
32 2.03M $15.21M 0.89%
0.89%
Reduce
33 89.08K $14.55M 0.85%
0.85%
Reduce
34 523.79K $14.47M 0.85%
0.85%
Reduce
35 364.22K $14.42M 0.85%
0.85%
Add
36 81.49K $14.11M 0.83%
0.83%
Reduce
37 426.58K $14.09M 0.83%
0.83%
Reduce
38 624.54K $13.87M 0.81%
0.81%
Reduce
39 185.78K $12.67M 0.74%
0.74%
Add
40 666.35K $12.41M 0.73%
0.73%
Add
41 283.52K $12.32M 0.72%
0.72%
Reduce
42 109.67K $12.13M 0.71%
0.71%
Reduce
43 672.22K $11.17M 0.66%
0.66%
Reduce
44 435.48K $11.15M 0.66%
0.66%
Reduce
45 921.39K $11.08M 0.65%
0.65%
Reduce
46 33.71K $10.73M 0.63%
0.63%
Reduce
47 234.70K $10.57M 0.62%
0.62%
Reduce
48 451.01K $10.51M 0.62%
0.62%
Reduce
49 305.78K $9.48M 0.56%
0.56%
Reduce
50 59.14K $9.46M 0.56%
0.56%
Hold

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2025-Q1?

In its 2025-Q1 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 248 equity positions worth $1.70B in aggregate; its largest disclosed positions were LRN ($58.76M), VRNA ($52.25M), ACIW ($50.64M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $1.70B of long equity holdings across 248 positions as of 2025-Q1. Top-10 holdings account for 26.3% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →